Evidence map›Paper›PMID 33094135›Full record

ArticleInternational journal of particle therapy2020

The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers.

Jaden D Evans, Riley H Harper, Molly Petersen, William S Harmsen, Aman Anand, Ashley Hunzeker, Noelle C Deiter, Heather Schultz, Krishan R Jethwa, Scott C Lester and 11 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of particle therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Analysis of the Rate of Re-planning in Spot-Scanning Proton Therapy.International journal of particle therapy · 2022
    Article
  10. Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma.Clinical and translational radiation oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Jaden D EvansDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Riley H HarperDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Molly PetersenDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
William S HarmsenDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Aman AnandDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Ashley HunzekerDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Noelle C DeiterDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Heather SchultzDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Krishan R JethwaDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Scott C LesterDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
David M RoutmanDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Daniel J MaDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Yolanda I GarcesDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Michelle A Neben-WittichDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Nadia N LaackDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Chris J BeltranDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Samir H PatelDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Lisa A McGeeDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Jean-Claude M RwigemaDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Daniel W MundyDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Robert L FooteDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USWinnMed · USMayo Clinic · USIntermountain Healthcare · USMayo Clinic in Florida · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

purposeTo understand how verification computed tomography-quality assurance (CT-QA) scans influenced clinical decision-making to replan patients with head and neck cancer and identify predictors for replanning to guide intensity-modulated proton therapy (IMPT) clinical practice. PATIENTS AND

methodsWe performed a quality-improvement study by prospectively collecting data on 160 consecutive patients with head and neck cancer treated using spot-scanning IMPT who underwent weekly verification CT-QA scans. Kaplan-Meier estimates were used to determine the cumulative probability of a replan by week. Predictors for replanning were determined with univariate (UVA) and multivariate (MVA) Cox model hazard ratios (HRs). Logistic regression was used to determine odds ratios (ORs).

resultsOf the 160 patients, 79 (49.4%) had verification CT-QA scans, which prompted a replan. The cumulative probability of a replan by week 1 was 13.7% (95% confidence interval [CI], 8.82-18.9), week 2, 25.0% (95% CI, 18.0-31.4), week 3, 33.1% (95% CI, 25.4-40.0), week 4, 45.6% (95% CI, 37.3-52.8), and week 5 and 6, 49.4% (95% CI, 41.0-56.6). Predictors for replanning were sinonasal disease site (UVA: HR, 1.82,

conclusionsWeekly verification CT-QA scans frequently influenced clinical decision-making to replan. Additional studies that evaluate the practice of monitoring IMPT-treated patients with weekly CT-QA scans and whether that improves clinical outcomes are warranted.

Indexed as

CT quality assuranceCT verificationhead and neck cancerIMPTproton therapy

Identifiers

PMID33094135
PMCPMC7574830
OpenAlexW3047292504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.